Background: The COVID-19 was the most amazing pandemic of the early third millennium, with significant variability in infection rates across regions worldwide. Genetic factors, particularly the ACE2 gene, coding for a common receptor implicated in facilitating SARS-CoV-2 entry into human cells, could play a crucial role in susceptibility to infection. Our study aimed to analyze the allelic frequency of four SNPs in ACE2 gene (rs4646127, rs2074192, rs2285666, rs112171234) and evaluate their correlations with COVID-19 infection rates in four regional samples from Morocco. Methods: The total sample ( N = 200) was obtained from: Rif ( n = 50), Doukkala ( n = 50), Ouarzazate ( n = 49), and, Guelmim ( n = 51). Genomic DNA was extracted using the GeneJET™ kit and genotyped by real-time PCR using TaqMan technology. Results: Analyses revealed significant spatial variations in the frequencies of alternative alleles of the studied SNPs, ranging from 0% to 74%. A significant positive correlation was observed between the frequency of alternative G allele of the rs4646127 and the infection rate variation ( r = 0.96; p = 0.03; n = 4). Furthermore, significant differences reached 54.17% with worldwide populations (from North Africa, sub-Saharan Africa, Europe, Latino-America, East Asia, and South Asia) for the total SNP’s comparisons. Conclusions: Our results suggest a significant positive correlation between the frequency of the alternative allele of the ACE2 gene polymorphism rs4646127 and COVID-19 regional infection rates in Morocco. This property could be exploited to consider this SNP as a potential biomarker for identifying at-risk groups. However, due to the limited number of regional samples, our results for all the analyzed SNPs remain exploratory and would require confirmation through larger-scale studies.
30 October 2026 in Genetic Testing and Molecular Biomarkers
Background: Metabolic syndrome (MetS) is a multifactorial condition and a major public health concern due to its strong association with cardiovascular disease and type 2 diabetes. Genetic factors contribute to its development. This study aims to evaluate the association between polymorphisms in genes APOA5 and CETP and susceptibility to MetS and its components in a Moroccan population. Methods: A case–control study was conducted, including 136 MetS patients and 138 controls recruited from the Doukkala region (Morocco). The APOA5 rs3135506 (C>G) and CETP rs708272 (G>A) polymorphisms were genotyped using PCR-RFLP. Results: The APOA5 rs3135506 polymorphism was significantly associated with increased MetS risk. The CG and GG genotypes conferred 2.39-fold (OR = 2.39; p = 0.0008) and 7.17-fold (OR = 7.17; p = 0.0007) higher risks, respectively, with significant associations also observed under dominant (OR = 2.76; p < 0.0001), recessive (OR = 4.79; p = 0.006), and allelic (OR = 2.36; p < 0.0001) models. The GG genotype was also associated with general and abdominal obesity, hypertension, and hyperglycemia, whereas the CG genotype was associated with dyslipidemia. For CETP rs708272, the AA genotype was associated with increased MetS risk (OR = 3.31; p = 0.0078), with significant associations under dominant (OR = 1.81; p = 0.0160), recessive (OR = 2.80; p = 0.0185), and allelic (OR = 1.81; p = 0.0023) models. However, these associations were no longer significant after adjustment for age and sex. Combined genotype analysis revealed increased MetS risk for the CG–GG, CG–GA, and GG–AA combinations (OR = 4.64, 2.98, and 7.35, respectively). Conclusion: The APOA5 rs3135506 and CETP rs708272 polymorphisms may contribute to MetS susceptibility in the Moroccan population, with certain combined genotypes associated with increased risk. These findings support their potential as genetic biomarkers for early risk assessment but require confirmation in larger studies.
7 August 2026 in Journal of Diabetes & Metabolic Disorders